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Abstract 1 
Background. Multiple individual vulnerabilities and traits are phenotypically associated with 2 
suicidal and non-suicidal self-harm. However, associations between these risk factors and 3 
self-harm are subject to confounding. We implemented genetically informed methods to 4 
better identify individual risk factors for self-harm.  5 
 6 
Methods. Using genotype data and online Mental Health Questionnaire responses in the UK 7 
Biobank sample (N = 125,925), polygenic risk scores (PRS) were generated to index 24 8 
plausible individual risk factors for self-harm in the following domains: mental health 9 
vulnerabilities, substance use phenotypes, cognitive traits, personality traits and physical 10 
traits. PRS were entered as predictors in binomial regression models to predict self-harm. 11 
Multinomial regressions were used to model suicidal and non-suicidal self-harm. To further 12 
probe the causal nature of these relationships, two-sample Mendelian Randomisation (MR) 13 
analyses were conducted for significant risk factors identified in PRS analyses. 14 
 15 
Outcomes. Self-harm was predicted by PRS indexing six individual risk factors, which are 16 
major depressive disorder (MDD), attention deficit/hyperactivity disorder (ADHD), bipolar 17 
disorder, schizophrenia, alcohol dependence disorder (ALC) and lifetime cannabis use. Effect 18 
sizes ranged from β = 0.044 (95% CI: 0·016 to 0·152) for PRS for lifetime cannabis use, to β 19 
= 0.179 (95% CI: 0·152 to 0·207) for PRS for MDD. No systematic distinctions emerged 20 
between suicidal and non-suicidal self-harm. In follow-up MR analyses, MDD, ADHD and 21 
schizophrenia emerged as plausible causal risk factors for self-harm.  22 
  23 
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Interpretation. Among a range of potential risk factors leading to self-harm, core predictors 1 
were found among psychiatric disorders. In addition to MDD, liabilities for schizophrenia 2 
and ADHD increased the risk for self-harm. Detection and treatment of core symptoms of 3 
these conditions, such as psychotic or impulsivity symptoms, may benefit self-harming 4 
patients.  5 
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Research in Context 1 
Evidence before this study 2 
A search was conducted on PubMed for literature from inception until 1st May 2019 using 3 
terms related to suicidal self-harm (SSH) and non-suicidal self-harm (NSSH), as well as 4 
polygenic risk scores (PRS), ("self-harm"[All Fields] OR "self-injurious"[All Fields] OR 5 
"self-mutilation"[All Fields] OR "suicide"[All Fields]) AND ("polygenic"[All Fields] OR 6 
"multifactorial inheritance"[All Fields]). Similar search was done for Mendelian 7 
Randomisation (MR), replacing “multifactorial inheritance” and “polygenic” with 8 
“Mendelian Randomisation/Randomization”. Evidence was included only if the study had 9 
used PRS or MR method to predict self-harm phenotypes using risk factors of self-harm. Ten 10 
papers for PRS and no paper for MR were identified.  11 
 12 
There were mixed results for PRS studies. PRS for MDD predicted SSH in two studies but 13 
not in another two studies. PRS for depressive symptoms predicted SSH but not NSSH.  PRS 14 
for schizophrenia predicted SSH in one but not in another two studies. PRS for bipolar 15 
disorder predicted SSH in one study but did not predict SSH nor NSSH in another two 16 
studies.  17 
 18 
Added value of this study 19 
By using a large population-based sample, we systematically studied individual 20 
vulnerabilities and traits that can potentially lead to self-harm, including mental health 21 
vulnerabilities, substance use phenotypes, cognitive traits, personality traits and physical 22 
traits, summing up to 24 PRS as genetic proxies for 24 risk factors. We conducted MR to 23 
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strengthen causal inference. We further distinguished non-suicidal self-harm (NSSH) and 1 
suicidal self-harm (SSH).  2 
 3 
Apart from PRS for schizophrenia, MDD and bipolar disorder, novel PRS were also 4 
identified to be associated with self-harm, which are PRS for attention-deficit hyperactivity 5 
disorder (ADHD), cannabis use and alcohol dependence. A larger sample size allowed us to 6 
confirm positive findings from the previously mixed literature regarding the associations 7 
between PRS for MDD, bipolar disorder, and schizophrenia with self-harm. Multivariate 8 
analyses and MR analyses strengthened the evidence implicating MDD, ADHD and 9 
schizophrenia as plausible causal risk factors for self-harm.       10 
 11 
Implications of all the available evidence 12 
Among the 24 risk factors considered, plausible causal risk factors for self-harm were 13 
identified among psychiatric conditions. Using PRS and MR methods and a number of 14 
complementary analyses provided higher confidence to infer causality and nuanced insights 15 
into the aetiology of self-harm. From a clinical perspective, detection and treatment of core 16 
symptoms of these conditions, such as psychotic or impulsivity symptoms, may prevent 17 
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Introduction 1 
Self-harm is a complex trait that refers to any act of self-injury and self-poisoning carried out 2 
by an individual, regardless of intention or motivation.1 Being a broadly defined term, it can 3 
be further categorised into suicidal self-harm (SSH) and non-suicidal self-harm (NSSH), i.e. 4 
with or without intention of suicide. According to a meta-analysis, the cross-national 5 
prevalence rate for NSSH peaks during adolescence (17.3%), and decreases among adults 6 
(5.5%).2 For SSH, the cross-national prevalence rate is also the highest among adolescents 7 
(9.7%)3 and drops among adults (2.7%).4 Recently, both SSH and NSSH were included in the 8 
fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) as 9 
separate conditions for further study.5 The distinction between SSH and NSSH may facilitate 10 
investigations of the aetiology and heterogeneity of self-harm. 11 
 12 
A range of individual vulnerabilities and traits can potentially lead to self-harm, such as 13 
psychiatric illnesses,6 substance use,7–9 cognitive abilities,10 personality traits11 and physical 14 
traits.12 Although associations between these risk factors and self-harm have been shown in 15 
numerous observational studies, causality is difficult to infer reliably. Genetically informed 16 
designs can help in strengthening causal inference.13 A polygenic risk score (PRS) is a single 17 
individual-level score computed in a given trait, weighted using summary statistics from an 18 
independent genome-wide association study (GWAS) for that particular trait. A PRS for an 19 
individual risk factor (e.g. schizophrenia) can be regarded as a genetic proxy for this risk 20 
factor.14 To illustrate, if schizophrenia is causally related to self-harm, a PRS for 21 
schizophrenia should also be associated with self-harm. A significant association between the 22 
PRS for schizophrenia and self-harm can be regarded as an initial indication of a possible 23 
causal relationship between the two. The PRS approach can be construed as a first step in a 24 
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series of genetically informed methods to investigate the aetiology of complex phenotypes, 1 
with follow-up steps including Mendelian Randomization (MR) discussed below.14–16  2 
 3 
In previous studies, a PRS for major depressive disorder (MDD) was found to be associated 4 
with SSH in two clinical samples17,18 and one non-clinical sample.19 However, this was not 5 
replicated in a family-based sample.20 A PRS for depressive symptoms predicted SSH but not 6 
NSSH in a twin sample.21 On the other hand, a PRS for schizophrenia was positively 7 
associated with SSH among offspring of suicide attempters,20 and a population sample,22 but 8 
not in another clinical sample.23 A PRS for bipolar disorder predicted SSH in one clinical 9 
sample24 but did not predict SSH nor NSSH among offspring of suicide attempters,20 and 10 
relatives of bipolar disorder patients.25     11 
 12 
The aforementioned PRS studies with mixed results were limited in several ways. Firstly, 13 
these studies focused on PRS for psychiatric disorders or psychiatric symptoms, and did not 14 
include potential risk factors from other domains, such as substance use7–9 , cognitive 15 
abilities,10 personality traits11 and physical traits.12 Secondly, with two exceptions,21,25 none 16 
of the studies had investigated SSH and NSSH simultaneously. Thirdly, these studies have a 17 
mixture of clinical and non-clinical samples with varying sample sizes ranging from 224 18 
individuals23 to 10,408 individuals,18 making any comparison difficult. In addition, none of 19 
these studies have implemented multivariate analyses including multiple PRS to better 20 
estimate their unique effect.  21 
 22 
A caveat of the PRS method is its proneness to unmediated (or horizontal) pleiotropy, arising 23 
from the inclusion of many thousands of genetic variants.14 Unmediated pleiotropy exists 24 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/673053doi: bioRxiv preprint first posted online Jun. 21, 2019; 
8 
when a genetic variant associated with an exposure causes the outcome through an alternative 1 
pathway, instead of via the exposure. Unmediated pleiotropy can generate associations 2 
between PRS and outcome in the absence of a causal relationship between the risk factors 3 
indexed by the PRS, and the outcome. Mendelian Randomisation (MR) can more stringently 4 
address unmediated pleiotropy and further strengthen causal inference. In MR, individual 5 
genetic variants associated with an exposure of interest are used as instrumental variables to 6 
infer causality between exposure and outcome. A number of complementary analyses, further 7 
detailed in the methods section, can be implemented to account for pleiotropy.16 To date, 8 
there is no published MR study which focuses on any risk factor of self-harm.  9 
 10 
The current study will address the aforementioned limitations by systematically using 24 PRS 11 
as proxies for risk factors from different domains to predict both NSSH and SSH, using a 12 
population-based sample of 125,925 individuals. We will conduct follow-up MR analyses to 13 
strengthen causal inference.  14 
 15 
Methods 16 
Participants  17 
The participants of the current study are a subset of the UK Biobank 18 
(http://www.ukbiobank.ac.uk). A total of 157,358 participants completed an online mental 19 
health questionnaire (MHQ) in a period from July 2016 to July 2017, which included 20 
questions regarding their lifetime symptoms of mental disorders.26 The participants were also 21 
genotyped. After the quality control (QC) process (see genotyping and QC details in 22 
supplementary materials), the final sample size was 125,925 individuals (56.2% females). 23 
Their ages ranged from 48 to 82 years, with a mean of 65.88 (SD = 7.69) years.  24 
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 1 
UK Biobank received ethical approval from the Research Ethics Committee (REC reference 2 
11/NW/0382). The current study was conducted under the UK Biobank application 18177. 3 
Data analysis was conducted from March 2018 to June 2019. 4 
 5 
Defining self-harm phenotypes 6 
To know whether the participants have ever-self-harmed, participants were asked “Have you 7 
deliberately harmed yourself, whether or not you meant to end your life?” To ascertain 8 
whether their self-harm episodes were NSSH or SSH, they were asked “Have you harmed 9 
yourself with the intention to end your life?”. In both questions, responses of “Prefer not to 10 
answer” (0.43%) were recoded as missing values. A flowchart depicting exclusion of 11 
participants and the number of participants who answered each question is shown in Figure 1. 12 
 13 
Statistical Analyses 14 
 15 
All statistical analyses were conducted in Linux environment using R version 3.5.0.27  16 
 17 
PRS analyses 18 
PRS of UK Biobank participants were generated using PRSice-228 based on their genotype 19 
data and 24 publicly available summary data from GWAS (see Table 1) selected based on the 20 
following criteria. First, we selected GWAS indexing individual vulnerabilities and traits that 21 
can potentially increase the risk of self-harm, including mental health vulnerabilities (e.g. 22 
MDD),29 cognitive abilities (e.g. education attainment),30 personality traits (e.g. 23 
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neuroticism),31 substance use phenotypes (e.g. cannabis use),32 and physical traits (e.g. 1 
BMI).12 Second, we selected GWAS which only included participants of European ancestry 2 
and did not include UK Biobank participants (to avoid overlapping between discovery sample 3 
size and target sample). Finally, we excluded GWAS with effective sample sizes less than N 4 
= 15,000 to limit the use of underpowered PRS.   5 
 6 
Each participant had 24 PRS, which were each calculated as the sum of alleles associated 7 
with their respective phenotypes, weighted by their effect sizes with p-values less than a 8 
threshold pT < 0.3 (selecting and reporting results from a single threshold allowed us to limit 9 
multiple testing, as done in previous PRS studies).22,33 Clumping was used to remove SNPs in 10 
linkage equilibrium (r2 < 0.1 within a 250 kb window). All PRS in the final analytical sample 11 
were standardised.    12 
 13 
Single PRS Binomial Logistic Regression 14 
For each PRS, a binomial logistic regression was conducted to test whether it predicted self-15 
harm (i.e. “Self-harmed” versus “Never self-harmed”).  16 
 17 
Multiple PRS Binomial Logistic Regression 18 
All PRS significantly associated with self-harm in single PRS binomial logistic regressions 19 
were then jointly modelled in a multivariate binomial logistic regression model to assess their 20 
unique effects.   21 
 22 
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Multinomial Logistic Regressions 1 
To investigate whether each PRS differentially predicted NSSH versus SSH, we fitted a 2 
series of multinomial logistic regression models. We first compared each of the NSSH and 3 
SSH groups to the never self-harmed group (i.e. “Never self-harmed” as the reference group). 4 
We then directly compared NSSH and SSH by testing a model with “NSSH” as the reference 5 
group.  6 
 7 
Covariates and multiple testing 8 
All regression models were controlled for sex, age and population stratification (by including 9 
assessment centre, genotyping batch and the first 6 principal components as covariates in the 10 
models). To control for multiple testing in single PRS binomial and multinomial regressions, 11 
we employed the false discovery rate (FDR) method34 which controls the expected proportion 12 
of false positives among the rejected hypotheses. We used q < .05 as the significance 13 
threshold.  14 
 15 
MR analyses 16 
All MR analyses were conducted using R package TwoSampleMR.35 Risk factors for which  17 
their PRS significantly predicted self-harm were selected for follow-up MR analyses. For 18 
self-harm in UK Biobank sample as the outcome for MR analyses, we obtained GWAS 19 
summary statistics from Neale Lab (http://www.nealelab.is/uk-biobank). SNPs of the 20 
exposures which passed the p-value threshold of p < 5E-5 were selected as instrumental 21 
variables for MR analyses. A liberal threshold was used to ensure that enough variants were 22 
available for all risk factors, including those with few genome-wide significant SNPs (e.g. 23 
ADHD). The strategy entails potential weak instrument bias. In two-sample MR, the resulting 24 
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bias is towards the null, making estimates more conservative (see below how this was dealt 1 
with).36 Clumping of SNPs with r2 < .001 within 250 kb was applied. SNPs in exposures and 2 
outcomes were harmonized by flipping alleles where possible, and we use allele frequencies 3 
to infer strands of ambiguous SNPs. Non-inferable SNPs with minor allele frequency > 0.42 4 
were discarded.  5 
 6 
We selected four MR methods which have different strengths and limitations. We conducted 7 
univariable MR using:  8 
(i) Inverse variance weighted (IVW) method, which is the most powerful method but 9 
cannot account for directional pleiotropy;37  10 
(ii) Robust Adjusted Profile Score (RAPS) method, which is used to account for the 11 
selection of weak instruments;33 12 
(iii) Weighted median method, as it is more robust to directional pleiotropy than IVW 13 
and is more robust to individual genetic variants with outlying causal estimates 14 
than IVW and MR-Egger;38 and  15 
(iv) MR-Egger regression method, whereby significance of its intercept term can 16 
inform on the presence of directional pleiotropy.39 17 
 18 
In addition, MR Steiger filtering40 was implemented to address the possibility of reverse 19 
causation (i.e. self-harm causing the putative risk factor). For each SNP, we expect that the 20 
effect size for the association with the exposure should be larger than the effect size for the 21 
association with the outcome. This is because the effect on the outcome is hypothesised to be 22 
indirect through the exposure. As such, all SNPs for which the effect size of the association 23 
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with the outcome was larger than the one with the exposure were filtered out before 1 
reimplementing MR. Finally, similar to PRS analyses, exposures which were significant in 2 
univariable MR were assessed for their independent effect in a multivariable MR model using 3 
the IVW method.  4 
 5 
For PRS analyses, we conducted further complementary analyses excluding cases with MDD 6 
and schizophrenia diagnoses to investigate the effect of genetic liability on self-harm with the 7 
influence of diagnoses excluded. We also calculated risk ratios for medicated and non-8 
medicated cases compared to those with median PRS in the general population (see 9 
supplementary materials for definitions of cases and medication). We created a quantile plot 10 
separating the participants into three groups: general population (in 20 quantiles), medicated 11 
cases and unmedicated cases, and calculated the risk ratios of these groups for self-harm 12 
relative to the group in the population with median PRS.  13 
 14 
Results 15 
Descriptive statistics 16 
Figure 1 shows the number of participants who: never self-harmed, self-harmed, engaged in 17 
SSH, and engaged in NSSH. Table 2 shows the gender proportion, and mean age of each 18 
subgroup.  19 
PRS analyses 20 
Single PRS binomial logistic regression 21 
Table 1 and Figure 2 show results from 24 single PRS binomial logistic regression tests, 22 
using each PRS as a predictor variable. Out of the 24 PRS, 10 PRS were significant 23 
predictors of self-harm at the nominal level (p < 0.05). After applying FDR correction, 6 PRS 24 
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had q-value < .05. In order of decreasing effect sizes, they are PRS for: MDD, schizophrenia, 1 
ADHD, bipolar disorder, alcohol dependence disorder (ALC), and lifetime cannabis use, with 2 
effect sizes ranging from β = 0·179 (95% CI: 0·152 to 0·207) for MDD, to β = 0·044 (95% 3 
CI: 0·016 to 0·072) for lifetime cannabis use. Figure S3 shows the pseudo R2 plots of these 6 4 
PRS in accounting for the variance in self-harm.      5 
 6 
Multiple PRS binomial logistic regression 7 
In the multiple PRS model, all PRS except the PRS for ALC had an independent effect of 8 
self-harm as shown in Table 1 and Figure 2. By controlling for the effects of other PRS, 9 
effect sizes of these PRS have diminished slightly compared to those in single PRS binomial 10 
logistic regression, ranging from β = 0·144 (95% CI: 0·115 to 0·173) for MDD to β = 0·031 11 
(95% CI: 0·002 to 0·060) for bipolar disorder. These PRS were weakly correlated, ranging 12 
from r = 0.01 (between bipolar disorder and ADHD) to r = 0.22 (between schizophrenia and 13 
bipolar disorder; see Table S3 for all correlations), suggesting that multicollinearity was not 14 
an issue.  15 
 16 
Single PRS multinomial logistic regression  17 
Table S1 shows results from 24 multinomial logistic regression tests, using PRS as predictor 18 
variable for three possible outcomes: “Never self-harmed”, “NSSH” and “SSH”. When 19 
“Never self-harmed” was used as the reference group, PRS for bipolar disorder, lifetime 20 
cannabis use and extreme BMI predicted SSH but not NSSH, with q < .05. However, when 21 
“NSSH” was set as the reference group in order to directly compare NSSH versus SSH, none 22 
of the PRS significantly distinguished between NSSH versus SSH.   23 
 24 
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MR analyses 1 
Table 3 shows the results from MR analyses. ADHD, ALC, bipolar disorder, lifetime 2 
cannabis use, MDD and schizophrenia were exposures in 6 separate univariable MR analyses, 3 
with self-harm as the outcome. Out of these 6 exposures, MDD, ADHD and schizophrenia 4 
had MR estimates with p-values < .05. For other exposures, none of their MR estimates had p 5 
< .05.  6 
 7 
For MDD, despite having the strongest IVW (β =0·008, 95% CI: 0·005 to 0·011, p = 2·84E-8 
08), MR RAPS (β =0·008, 95% CI: 0·005 to 0·011, p = 1·24E-07), and weighted median (β = 9 
0·006, 95% CI: 0·001 to 0·011, p = 0·013) estimates among the three exposures, the MR 10 
Egger estimate was not significant. On the other hand, all MR estimates for ADHD and 11 
schizophrenia were significant.  12 
 13 
The significance of intercept terms in MR-Egger test indicates the presence of pleiotropy. Out 14 
of the 6 exposures in MR-Egger test, none of the intercept terms were significant, except for 15 
MDD (p = 0·023). MR Steiger directionality tests could only be applied to test the direction 16 
of causality between ADHD, MDD and schizophrenia with self-harm because the summary 17 
statistics for other exposures did not contain information about allele frequencies, which are 18 
needed for the test. MR Steiger directionality test showed that all SNPs of MDD, 19 
schizophrenia and ADHD are more predictive of the respective exposures than self-harm, 20 
suggesting that reverse causation unlikely explained our findings.   21 
 22 
When ADHD, MDD and schizophrenia were included as exposures in multivariable IVW 23 
MR analysis, only MDD (β = 0.011, 95% CI: 0·007 to 0·015, p = 1·04E-12) and 24 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/673053doi: bioRxiv preprint first posted online Jun. 21, 2019; 
16 
schizophrenia (β = 0·002, 95% CI: 4·00E-05 to 0·004, p = 0·002) remained as independent 1 
predictors of self-harm. Due to the potential presence of pleiotropy between MDD and self-2 
harm, another multivariable IVW MR model was conducted with only ADHD and 3 
schizophrenia as exposures. Both ADHD (β = 0.003, 95% CI: 0.001 to 0.005, p = 2.21E-04) 4 
and schizophrenia (β = 0.003, 95% CI: 0.002 to 0.004, p = 7.60E-07) were significant 5 
predictors in this model.  6 
 7 
In PRS complementary analyses which excluded cases, PRS for MDD and schizophrenia still 8 
predicted self-harm in a healthy, screened cohort, indicating that genetic liabilities can predict 9 
self-harm when influence of diagnoses is excluded (See Table S2). In the quantile plot, cases 10 
for schizophrenia and MDD appear to be at much larger risk for self-harm than the rest of the 11 
population. Medicated MDD cases were at higher risk of self-harm than non-medicated MDD 12 
cases, which was not the case for schizophrenia (See Figure 3).   13 
 14 
Discussion 15 
To our knowledge, this is the first study using multiple PRS as genetic proxies to 16 
systematically investigate a range of individual vulnerabilities and traits as risk factors for 17 
self-harm in a large population sample. In PRS analyses, we identified 6 risk factors (i.e. 18 
MDD, schizophrenia, ADHD, bipolar disorder, ALC, and lifetime cannabis use) which 19 
predicted self-harm. Five among six (except for ALC) remained significant in a multiple PRS 20 
regression. We found no evidence of differential prediction for SSH versus NSSH. In follow-21 
up MR analyses, MDD, schizophrenia and ADHD emerged as plausible causal risk factors 22 
for self-harm, despite evidence of unmediated pleiotropy for MDD. We discuss in turn: (1) 23 
insights into the aetiology of self-harm, and (2) clinical implications. 24 
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 1 
Insights into the aetiology of self-harm 2 
Results from our PRS methods corroborated previous observational findings where MDD,6 3 
schizophrenia,41 ADHD,42 bipolar disorder,6 and ALC8 were phenotypically associated with 4 
self-harm. Our results are also consistent with positive associations found in PRS studies for 5 
MDD,17,19,43 schizophrenia,20 and bipolar disorder24. Previous mixed findings for these PRS 6 
may have stemmed from lack of power, as sample sizes for those studies varied widely. The 7 
current study adds lifetime cannabis use, ADHD, and ALC as novel PRS associated with self-8 
harm. However, when controlling for other PRS, the PRS for ALC did not significantly 9 
predict self-harm. This finding may suggest that the genetic liability for ALC does not 10 
independently predict self-harm when the effect of genetic liability for MDD, bipolar 11 
disorder, schizophrenia, ADHD and lifetime cannabis are accounted for. For example, ALC 12 
may be a marker for a true predictor such as impulsivity which is more efficiently captured in 13 
the PRS for ADHD.44 . Alternatively, null findings for ALC can also plausibly be due to a 14 
lack of power compared to other polygenic scores. Hence, we cannot completely rule out that 15 
the PRS for ALC has an independent effect on self-harm and the corresponding causal effect 16 
of ALC on self-harm. 17 
 18 
Most of the PRS which predicted self-harm in the current study relate to psychiatric 19 
conditions, which confirms the prominence of psychiatric conditions in the aetiology of self-20 
harm.45 Beyond psychiatric conditions, cognitive traits, physical traits, and personality traits 21 
were not found to be associated with self-harm using PRS approach, although previous 22 
observational findings found significant phenotypic associations for these three domains.10–12 23 
The absence of significant findings in this case is unlikely to be solely due to lack of power, 24 
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given that GWAS for some of these traits are more powerful than GWAS for psychiatric 1 
conditions (e.g. BMI and education attainment). These findings suggest that these traits and 2 
vulnerabilities are unlikely to have (strong) causal effects on self-harm. 3 
 4 
Our MR analyses provided further support for the role of MDD, ADHD, and schizophrenia in 5 
the aetiology of self-harm. An intriguing finding is the presence of significant pleiotropy in 6 
the case of MDD. Rather than signifying that MDD does not have a causal effect on self-7 
harm, this may reflect a possible measurement issue. Indeed, one of the diagnostic criteria for 8 
MDD is related to having suicidal thoughts and attempts, which could artificially introduce a 9 
pleiotropic effect.5 To deal with this issue, future studies may rely on a GWAS for MDD 10 
excluding the diagnostic criteria related to suicidal thoughts and attempts. This might also 11 
explain why, in multivariate MR, the effect of ADHD was no longer significant – as we 12 
partially controlled for self-harm – whereas it was significant when only considering ADHD 13 
and schizophrenia. 14 
 15 
The current study found mixed results for whether there are distinct aetiologies for SSH and 16 
NSSH. Most PRS which predicted self-harm also predicted both SSH and NSSH, except 17 
bipolar disorder, lifetime cannabis use and extreme BMI, which only predicted SSH but not 18 
NSSH from those who never self-harmed. However, in a formal test comparing NSSH and 19 
SSH, the estimates of these three risk factors were not significantly different between NSSH 20 
and SSH. Hence, our findings do not provide evidence for marked differences in aetiology 21 
between SSH and NSSH.  22 
 23 
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Clinical implications  1 
The current study suggests that individual vulnerabilities and traits underlying self-harm most 2 
likely relate to psychiatric conditions such as MDD and schizophrenia, rather than to other 3 
domains such as personality traits. Hence, treatments focusing on the core symptoms of these 4 
psychiatric conditions are important in preventing or addressing the risk of self-harm. 5 
Findings from PRS analyses suggest that genetic liabilities for these conditions increase the 6 
likelihood of self-harm even in those not clinically diagnosed. This may suggest that 7 
subthreshold symptoms of these core psychiatric conditions may increase the risk of self-8 
harm. Clinicians may want to systematically test for such symptoms in self-harming patients. 9 
Future investigations may test whether drugs for such core conditions may be repurposed for 10 
treating self-harming patients, with either full blown or subthreshold conditions. For example, 11 
prescription of methylphenidate for ADHD treatment was found to be associated with 12 
reduction of suicide attempt risk.46 As a note of caution, treated schizophrenia cases were not 13 
at less risk of self-harm than non-treated patients whereas treated MDD patients were at 14 
substantial higher risk for self-harm. This could be due to treated patients having more severe 15 
symptoms than untreated patients, or it could be due to adverse effects of medication, in 16 
particular in the case of MDD where suicidality might be an adverse effect of antidepressant 17 
treatment.47  18 
 19 
Limitations 20 
In order to avoid the overlapping of discovery and target sample, we excluded GWAS which 21 
contain UK Biobank sample, resulting in selecting older GWAS for generating PRS in some 22 
cases. This might have led to non-significant findings due to lack of power. The results 23 
should be generalised with caution because UK Biobank is not representative of the UK 24 
population as they are more educated, older, wealthier, and healthier.48 The questions asked 25 
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in MHQ were retrospective and their formulation led to an exclusive dichotomy between 1 
NSSH or SSH, whereby some might have engaged in both NSSH and SSH at different times.  2 
 3 
Conclusion 4 
Among 24 PRS used as genetic proxies for vulnerabilities and traits possibly associated with 5 
self-harm, we found that PRS for MDD, schizophrenia, ADHD, bipolar disorder, ALC and 6 
cannabis were statistically significant. After a series of complementary analyses to further 7 
strengthen the causal inference, schizophrenia survived as the most plausible causal risk 8 
factor, followed by MDD and ADHD.  Detection and treatment of core symptoms of these 9 
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Figures and Tables 1 
Figure 1. Flowchart showing the number of participants at each stage. 2 
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 1 
Figure 2. Estimates from single PRS regression and multiple PRS regression in decreasing 2 
effect sizes. (1) indicates not significant in multiple PRS regression. (2) indicates not 3 
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 1 
Figure 3. Relative risks of general population, non-medicated cases and medicated cases in 2 
self-harming compared to those with median PRS (11th quantile) in schizophrenia (A) and 3 
MDD (B). Out of 177 schizophrenia cases in the final analytical sample, 89 (50·3%) of them 4 
were medicated. Out of 34,680 MDD cases in the final analytical sample, 7,852 (22·6%) of 5 
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Table 1. Single and multiple PRS prediction of self-harm. 1 
Traits/disorders Discovery Sample size 
Single PRS binomial model Multiple PRS binomial model 
b 95% CI p-value q-value b 95% CI p-value 
Mental health vulnerabilities 
ADHD symptoms49  17,666 0·030  0·003, 0·058 0·030 0·074 -   - 
ADHD50 49,017* 0·124  0·097, 0·152 6·69E-19 8·02E-18 0·089 0·062, 0·116 4·24E-10 
Alcohol dependence disorder51 42,803* 0·045  0·016, 0·073 2·03E-03 0·008 0·024 -0·005, 0·053 0·101 
Anxiety disorders meta-analysis: 
factor scores52 18,186 0·026  -0·001, 0·053 0·060 0·121 - 
  - 
  
Anxiety disorders meta-analysis: 
case-control52 17,310*   0·022 -0·005, 0·049 0·116 0·199 -   - 
Bipolar disorder53 16,544* 0·067 0·040, 0·095 1·74E-06 1·05E-05 0·031 0·002, 0·060 0·033 
MDD29 124,331* 0·179 0·152, 0·207 5·52E-37 1·33E-35 0·144 0·115, 0·173 3·99E-23 
Schizophrenia54 75,846* 0·128 0·100, 0·157 2·43E-18 1·94E-17 0·094 0·065, 0·123 6·99E-10 
Substance use phenotypes 
Lifetime cannabis use32 31,933* 0·044 0·016, 0·072 0·002 0·008 0·036 0·009,0·063 0·013 
Cigarettes per day55 38,181 -0·014 -0·041, 0·014 0·329 0·465 - - - 
Daily alcohol use56 70,460 0·001 -0·031, 0·033 0·959 0·991 - - - 
Cognitive trait 
Education attainment30 106,736 1·69E-04 -0·028, 0·029 0·991 0·991 - - - 
Personality traits 
Conscientiousness57 17,375 -0·009 -0·037, 0·019 0·524 0·599 - - - 
Extraversion58 63,030 -0·017 -0·045, 0·010 0·214 0·343 - - - 
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Neuroticism: Item Response 
Theory (IRT)31 63,661 0·031 
0·004, 0·058 0·025 0·074 - - - 
Agreeableness57 17,375 -0·011 -0·039, 0·016 0·414 0·523 - - - 
Aggression59 18,988 0·023 -0·005, 0·050 0·107 0·198 - - - 
Antisocial behaviour60 16,400 0·027 6·46E-05, 0·055 0·049 0·108 - - - 
Physical traits 
Birth length61 28,459 -0·008 -0·035, 0·020 0·592 0·646 - - - 
Birth weight62 26,836 0·030 0·003, 0·058 0·031 0·074 - - - 
Adult height63 253,288 -0·018 -0·057, 0·021 0·365 0·486 - - - 
Overweight64 154,206* 0·011 -0·017, 0·038 0·440 0·527 - - - 
Extreme BMI64 16,067* 0·031 0·004, 0·059 0·024 0·074 - - - 
BMI65 322,154 0·016 -0·012, 0·044 0·259 0·388 - - - 
Note: Sample size with asterisks (*) are GWAS with case-control samples, and the effective sample sizes are calculated using the formula 1 Neffective=4/(1/Ncases+1/Ncontrols) whenever possible. The p-values or q-values in bold are those that met the nominal p < ·05 or 2 
corrected q < ·05 thresholds. 3 
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Table 2. Descriptive statistics for each subgroup of self-harm related phenotypes.  1 




SD of age 
(years) 
Full analytical sample 56·2 65·9 7·7 
Self-harmed 69·4 62·3 7·5 
SSH 68·0 63·1 7·4 
NSSH 70·5 61·4 7·5 
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Table 3. Univariable and multivariable MR analyses 1 
Exposure Univariable MR Multivariable MR 
method nsnp b LowCI UpCI pval nsnp b lowCI UpCI p-value 
ADHD IVW 244 0·003 0·001 0·005 0·001 1206 0·001 -0·001 0·003 0·269 
MR RAPS 0·003 0·001 0·005 0·001 
Weighted median 0·003 2·83E-04 0·005 0·028 
MR Egger 0·006 0·001 0·011 0·031 




IVW 86 0·001 -4·50E-04 0·003 0·157 - - - - - 
MR RAPS 0·001 -4·57E-04 0·003 0·150 
Weighted median 0·001 -0·001 0·004 0·332 
MR Egger 0·001 -0·002 0·005 0·465 
MR Egger intercept -1·88E-05 -5·85E-04 5·48E-04 0·948 
Bipolar disorder IVW 77 0·001 -0·001 0·003 0·310 - - - - - 
MR RAPS 0·001 -0·001 0·003 0·355 
Weighted median 1·27E-04 -0·002 0·003 0·922 
MR Egger 3·22E-04 -0·008 0·008 0·936 
MR Egger intercept 8·31E-05 -9·39E-04 1·11E-03 0·874 
Lifetime 
cannabis use 
IVW 85 -2·07E-04 -0·002 0·001 0·787 - - - - - 
MR RAPS -2·85E-04 -0·002 0·001 0·730 
Weighted median -0·001 -0·004 0·001 0·314 
MR Egger -0·002 -0·006 0·001 0·171 
MR Egger intercept 3·62E-04 -1·38E-04 8·61E-04 0·160 
MDD IVW 239 0·008 0·005 0·011 2·84E-08 1206 0·011 0·007 0·015 1·04E-12 
MR RAPS 0·008 0·005 0·011 1·24E-07 
Weighted median 0·006 0·001 0·011 0·013 
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MR Egger 0·002 -0·004 0·008 0·463 
MR Egger intercept 4·20E-04 6·06E-05 7·80E-04 0·023 
Schizophrenia IVW 1003 0·003 0·002 0·004 1·54E-09 1206 0·002 4·00E-05 0·004 0·002 
MR RAPS 0·003 0·002 0·004 2·89E-09 
Weighted median 0·003 0·002 0·005 1·80E-05 
MR Egger 0·004 0·001 0·007 0·009 
MR Egger intercept -4·84E-05 -2·42E-04 1·45E-04 0·625 
Note. The p-values in bold are those that met the p <·05 threshold. 1 
 2 
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